掺入溴敌隆的合成大麻素中毒的影像学表现
这项回顾性研究利用以色列中毒信息中心数据库,纳入2021年9月至2022年6月北部暴发期间在Rambam Health Care Campus就诊的48例合成大麻素相关凝血病患者,回顾其影像学检查。腹部CT上可见特征性泌尿道黏膜下出血(18例中16例,敏感度89%),胃肠道出血患者中70%见肠壁内血肿;出血部位数量增多与需使用血管升压药相关。
要点
- 掺入溴敌隆的合成大麻素中毒可致严重凝血病,CT为诊断和评估的关键手段。
- 腹部CT特征性征象为泌尿道黏膜下出血,对凝血病敏感度89%(CI 65-99%)。
- 胃肠道出血患者中70%(7/10)CT见肠壁内血肿。
核心结论
- CT在掺入溴敌隆的合成大麻素相关凝血病的诊断和评估中起关键作用,特征性征象包括泌尿道黏膜下出血和肠壁内血肿。
研究设计与样本
- 回顾性研究,利用以色列中毒信息中心数据库识别2021年9月至2022年6月北部暴发期间在Rambam Health Care Campus就诊的合成大麻素相关凝血病患者,共48例(平均年龄40岁±9[SD],43例男性),54次住院,回顾所有相关影像学检查。
关键影像表现/征象
- 腹部CT显示特征性泌尿道黏膜下出血,18例接受腹部CT的患者中16例出现。
- 胃肠道出血患者的CT中70%(7/10)见肠壁内血肿。
- 24%的患者在影像上发现偶然出血部位。
诊断标准与关键数值
- 泌尿道黏膜下出血对合成大麻素相关凝血病的敏感度为89%(CI 65-99%)。
临床应用与阅片要点
- 在疑似掺入溴敌隆的合成大麻素中毒患者中,CT上识别泌尿道黏膜下出血和肠壁内血肿有助于诊断。
- 影像上偶然发现的出血部位可能提示凝血病,需结合临床。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Severe coagulopathy due to consumption of synthetic cannabinoids adulterated with brodifacoum, a long-acting anticoagulant, is an emerging worldwide hazard. Here, we review the spectrum of imaging findings in adulterated cannabinoid poisoning.
MATERIALS AND METHODS: In this retrospective study, we used the Israeli Poison Information Center database to identify patients with cannabinoid-associated coagulopathy who presented to the Rambam Health Care Campus, where most patients were treated during an outbreak in northern Israel between September 2021 and June 2022. All relevant imaging studies for these patients were reviewed. We estimated the sensitivity of findings for cannabinoid-associated coagulopathy. Associations between a continuous variable and a dichotomous outcome were assessed with the Mann-Whitney U test.
RESULTS: We identified 48 patients (mean age 40 years ± 9 [SD], 43 males) with 54 hospitalizations due to cannabinoid-associated coagulopathy. Symptomatic hemorrhage was documented in 50 (93%) cases at presentation, most of whom (78%) had hemorrhage from multiple systems. The most common bleeding site was the genitourinary collecting system, with a characteristic sign of suburothelial bleeding in 16/18 of performed abdominal CTs (sensitivity 89% [CI 65-99%] for cannabinoid-associated coagulopathy). Intramural bowel hematomas were noted in 70% (7/10) of CTs of patients with gastrointestinal bleeding. Incidental bleeding sites were identified on imaging in 24% of patients. An increased number of bleeding sites was associated with need for vasopressors (difference in bleeding sites 3.00 [95% CI 0.99-4.00], p = 0.026).
CONCLUSION: CT plays a key role in the diagnosis and work-up of adulterated cannabinoid-associated coagulopathy. Characteristic signs include suburothelial hemorrhage and intramural bowel hematomas.
CLINICAL RELEVANCE STATEMENT: Recognition of radiological signs of adulterated synthetic cannabinoid-associated coagulopathy is critical for optimizing outbreak control on the public health level and ensuring timely treatment on the individual patient level.
KEY POINTS: • Severe coagulopathy due to consumption of synthetic cannabinoids adulterated with brodifacoum, a long-acting anticoagulant, is an emerging worldwide threat. • Characteristic imaging signs include suburothelial bleeding, intramural bowel hematomas, and rare incidental bleeding sites. • Imaging has a pivotal role in optimizing outbreak control and ensuring timely and appropriate treatment.
引用
- Bar N, Lopez-Alonso R, Merhav G, et al. Radiological findings in poisoning by synthetic cannabinoids adulterated with brodifacoum. Eur Radiol. 2023. PMID: 38127072. doi:10.1007/s00330-023-10496-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。